Synovics Pharmaceuticals

SYVC · OTC

$0.0001+$0.0001 (+9900.00%)TodayMarket closed ·
No price history for this range.

About SYVC

Synovics Pharmaceuticals, Inc. engages in the manufacture and sale of pharmaceutical and dietary supplement products. The company is headquartered in Fort Lauderdale, Florida and currently employs 155 full-time employees. The firm is a manufacturer, packager and distributor of private label, or store brand, OTC products to chain drug stores, wholesalers and distributors throughout the United States. The Company’s OTC product categories include analgesics, cough and cold, antihistamines, asthma relief and laxatives. The firm has two primary subsidiaries, Kirk Pharmaceuticals, LLC (Kirk), and ANDAPharm, LLC (ANDAPharm). Kirk manufactures and distributes OTC products developed by or licensed to the Company. ANDAPharm serves as the product research and RX manufacturing arm of the Company with a focus on the development of active compounds for drugs.

Employees
155
Headquarters
FORT LAUDERDALE, Florida
Listed
Dec 19, 1994
Sector
Health Care
Industry
Pharmaceuticals

SYVC key statistics

Market cap
2.98K
Price-earnings ratio
—
Dividend yield
—
Average volume
5.58K
Volume
14.93K
Open price
$0.0001
High today
$0.0001
Low today
$0.0001
52 Week high
$0.0001
52 Week low
$0.00

Synovics Pharmaceuticals (SYVC) at a glance

Synovics Pharmaceuticals (SYVC) last traded at $0.0001, with a market cap of 2.98K.

Volume so far is 14.93K shares, above the average of 5.58K shares a day.

Over the past year Synovics Pharmaceuticals has ranged from $0.00 to $0.0001, and now sits 100% of the way up that range.

Similar companies

Companies in the same industry as Synovics Pharmaceuticals

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.